BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19931574)

  • 1. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
    Conlon JM
    Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granins and granin-related peptides in neuroendocrine tumours.
    Portela-Gomes GM; Grimelius L; Wilander E; Stridsberg M
    Regul Pept; 2010 Nov; 165(1):12-20. PubMed ID: 20211659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
    Portela-Gomes GM; Grimelius L; Stridsberg M
    Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.
    Helle KB
    Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions.
    Helle KB
    Regul Pept; 2010 Nov; 165(1):45-51. PubMed ID: 19800929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of chromogranin B can serve as a complement to chromogranin A.
    Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
    Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
    Nunzi MG; Mugnaini E
    Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A,B and secretogranin II.
    Prommegger R; Obrist P; Ensinger C; Schwelberger HG; Wolf C; Fischer-Colbrie R; Mikuz G; Bodner E
    Anticancer Res; 1998; 18(6A):3999-4002. PubMed ID: 9891437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granin-derived peptides.
    Troger J; Theurl M; Kirchmair R; Pasqua T; Tota B; Angelone T; Cerra MC; Nowosielski Y; Mätzler R; Troger J; Gayen JR; Trudeau V; Corti A; Helle KB
    Prog Neurobiol; 2017 Jul; 154():37-61. PubMed ID: 28442394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease.
    Watanabe T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Janson ET
    Regul Pept; 2008 Jun; 148(1-3):95-8. PubMed ID: 18448176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical diagnosis of neuroendocrine GEP tumor.
    Oberg K
    Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranins A and B and secretogranin II: evolutionary and functional aspects.
    Montero-Hadjadje M; Vaingankar S; Elias S; Tostivint H; Mahata SK; Anouar Y
    Acta Physiol (Oxf); 2008 Feb; 192(2):309-24. PubMed ID: 18005393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A.
    Hendy GN; Bevan S; Mattei MG; Mouland AJ
    Clin Invest Med; 1995 Feb; 18(1):47-65. PubMed ID: 7768066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
    Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
    Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromogranin A and neuroendocrine tumors].
    Díaz Pérez JÁ; Currás Freixes M
    Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catestatin--a novel neuropeptide in carcinoid tumors of the appendix.
    Prommegger R; Ensinger C; Adlassnig C; Vaingankar S; Mahata SK; Marksteiner J; Margreiter R
    Anticancer Res; 2004; 24(1):311-6. PubMed ID: 15015613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.